The mixed analyst ratings for Molina Healthcare indicate that there is no clear consensus on the stock's short-term price direction. The average 12-month price target has decreased by 3.07% from the previous average, suggesting that analysts may have slightly lowered their expectations for the stock. However, the overall impact on the stock price is likely to be neutral in the short term, as the ratings are not overwhelmingly bullish or bearish.